Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

1,184

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Brinzolamide 1%/brimonidine tartrate 0.2% fixed combination ophthalmic suspension

DRUG

Vehicle

Inactive ingredients used as a placebo for masking purposes

DRUG

Brinzolamide 1% ophthalmic suspension

DRUG

Brimonidine tartrate 0.2% ophthalmic solution